Theratechnologies Beta
Cos'è Beta di Theratechnologies?
Beta di Theratechnologies Inc. è 2.11
Qual è la definizione di Beta?
BETA indica se una azione è più o meno volatile rispetto al mercato nel suo complesso. Un beta inferiore a 1 indica che la azione è meno volatile rispetto al mercato, mentre un beta più di 1 indica che la azione è più volatile. La volatilità è misurata come la fluttuazione del prezzo attorno alla media.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta di aziende nel Health Care settore su NASDAQ rispetto a Theratechnologies
Cosa fa Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Aziende con beta simili a Theratechnologies
- Applied Materials ha Beta di 2.11
- goeasy ha Beta di 2.11
- Melcor Real Estate Investment Trust ha Beta di 2.11
- THEMAC Resources ha Beta di 2.11
- Nova Royalty ha Beta di 2.11
- Vornado Realty Trust ha Beta di 2.11
- Theratechnologies ha Beta di 2.11
- Big Tree Carbon Inc ha Beta di 2.11
- ENENSYS Technologies SA ha Beta di 2.11
- Zillow Inc ha Beta di 2.11
- Jadestone ha Beta di 2.11
- Last Mile ha Beta di 2.11
- Bid ha Beta di 2.11